Macrogenics (MGNX) analyst forecast and price target
Analyst forecast
Consensus of 6 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| B. Riley Securities | Maintained | Buy | $11.00 from $9.00 | Aug 17, 2026 |
| Barclays | Maintained | Overweight | $6.00 from $4.00 | Apr 20, 2026 |
| B. Riley Securities | Upgraded | Neutral → Buy | $9.00 from $3.00 | Apr 10, 2026 |
| Barclays | Maintained | Overweight | $4.00 from $3.00 | Mar 10, 2026 |
| HC Wainwright & Co. | Maintained | Neutral | $2.00 | Nov 3, 2025 |
| Barclays | Initiated Coverage | Overweight | $3.00 | Sep 17, 2025 |
| Leerink Partners | Maintained | Outperform | $5.00 from $8.00 | Aug 15, 2025 |
| B. Riley Securities | Maintained | Neutral | $3.00 from $5.00 | May 20, 2025 |
| Barclays | Maintained | Overweight | $3.00 from $8.00 | May 14, 2025 |
| Stifel | Maintained | Hold | $5.00 from $6.00 | May 14, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | $2.00 from $4.00 | Mar 25, 2025 |
| JMP Securities | Downgraded | Market Outperform → Market Perform | — | Nov 7, 2024 |
| HC Wainwright & Co. | Maintained | Neutral | $4.00 | Nov 6, 2024 |
| HC Wainwright & Co. | Maintained | Neutral | $4.00 | Sep 18, 2024 |
| HC Wainwright & Co. | Maintained | Neutral | $4.00 | Aug 21, 2024 |
| Citigroup | Maintained | Buy | $14.00 from $16.00 | Aug 15, 2024 |
| BMO Capital | Maintained | Market Perform | $5.00 from $8.00 | Aug 7, 2024 |
| HC Wainwright & Co. | Maintained | Neutral | $4.00 | Aug 1, 2024 |
| BTIG | Downgraded | Buy → Neutral | — | Aug 1, 2024 |
| B. Riley Securities | Downgraded | Buy → Neutral | $5.00 from $18.00 | Jul 31, 2024 |
Frequently asked questions
Is MGNX a buy, sell, or hold?
Analysts covering Macrogenics currently average a Buy rating: 3 buy, 3 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on MGNX?
On Aug 17, 2026, B. Riley Securities maintained Macrogenics at Buy with a price target of $11.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.